QRM Process

Boehringer Ingelheim Unit Looks to Sell Generics Business

Source: pharmamanufacturing.com

Dec 05, 2013

Reuters.com

Ben Venue Laboratories, the Bedford, Ohio-based subsidiary of German drugmaker Boehringer Ingelheim, has hired Bank of America Merrill Lynch to explore a possible sale of its generic sterile injectable drugs business.

Ben Venue had struggled to keep the Ohio site open after a series of drug quality problems and had been operating under a consent decree with FDA until ultimately deciding in October to cease production and avoid additional investment.

No potential sale price or bidders have been mentioned yet.

Read the Reuters release